Tag Archives: innovation

BayBio Op-ed featured in Xconomy

GM

Gail Maderis, President & CEO of BayBio, recently discussed the strength of Northern California’s biotechnology industry and the BIO Investor Forum in Xconomy: With more than 850 biotechnology companies, the Bay Area is the oldest, largest and most productive life sciences cluster in the world, employing more than 125,000 people in the region. For more than 30 years, this region has led the world in researching and delivering new cures and treatments for debilitating diseases Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

National Bioeconomy Blueprint

Jim Greenwood

Today, the White House released its National Bioeconomy Blueprint.  The Blueprint defines the bioeconomy as, “economic activity that is fueled by research and innovation in the biological sciences” and identifies the bioeconomy as a priority for the Obama Administration. BIO provided input and submitted ideas to the Administration after it announced the development of the Blueprint last Fall. While the Administration has largely been focused on advancing innovation in areas such as electronic devices, social Read More >

Jim's Corner  |  2 Comments  |  Email This Post
Tags: , , , , , ,

The Real Reason Why Salk Refused to Patent the Polio Vaccine

Vaccine

A guest writer in a recent article in the Wall Street Journal repeated the oft quoted Jonas Salk statement about his Polio vaccine: “There is no patent.  Could you patent the sun?”  Many use this statement as the moral impetus for refusing patents on medically important innovations (see Michael Moore’s Capitalism: A Love Story).  Unfortunately, Jonas Salk created a myth that day by leaving out several crucial details. As pointed out by Robert Cook-Deegan at Read More >

Patently BIOtech  |  16 Comments  |  Email This Post
Tags: , , , , , , ,

Brazilian Innovation: A Patent Success

plant

The story of Acheflan highlights the role of patents in homegrown innovation in developing countries.  Professor Michael Ryan of George Washington University Law School reviewed several case studies (including Acheflan) in Brazil that highlight the differences in biomedical innovation both pre- and post-intellectual property reforms. In the early 1980’s, Ache Laboratorios Farmaceuticos (a Brazilian generics manufacturer) became aware of a plant that grew near coastal cities that local fishermen would mash into an oil rub Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Biomedical Innovation: How the U.S. Can Stay Number One

lab_tech02-thumb

By Ross DeVol, chief research officer of the Milken Institute “The first step in winning the future is encouraging American innovation,” declared President Obama in his last State of the Union speech. A logical place to start is making sure that where we hold a lead, we keep it. Today, the U.S. has such a lead in biomedical innovation — the process of transforming scientific discoveries into vaccines, diagnostics, devices and therapies that improve and Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,